Teva's New State-of-the-Art R&D Extension

The President of the Republic of Croatia, Dr. Ivo Josipović, officially opened the new R&D extension for complex molecules and new therapeutic entities at PLIVA, Teva Croatia's Research Institute, on Monday, December 1st, 2014.

Teva's New State-of-the-Art R&D Extension

The official opening was attended by renowned members of the local professional and scientific communities. Those in attendance made a tour of the new cutting-edge laboratories and attended presentations on future challenges in the pharmaceutical industry.

Croatian President Josipović visited Teva’s offices in Israel with a Croatian delegation two years ago. He was significantly impressed with the size of Teva’s investments in Croatia.

“At a time when we are fighting recession and losing self-confidence, the fact that we have such a company, which is expanding its operations and impact beyond Croatia, fills us with hope that we can do the same as a society.”, said President Josipović, addressing the audience at Teva’s R&D Center of Excellence.

He added that Teva was an excellent example of partnership between the business sector, the academic community and the labor market. He further expressed his belief that this cooperation would enable the development of new technologies and employment for young and highly educated people.

Dr. Michael Hayden, President of Teva’s Global R&D and Chief Scientific Officer, noted, “Our R&D Center in Zagreb is the largest pharmaceutical R&D center in Croatia, and the 3rd largest in Teva’s R&D network. The people we employ in Zagreb know they are not just part of a local operation. They are right at the heart of something much bigger. They are driving highly complex projects, requiring intimate knowledge of international regulatory requirements and working hand-in-hand with a truly global team. This enables us to meet the needs of our patients worldwide.“

Tim Orešković, President of PLIVA’s Management Board, also said, “I am exceptionally proud that Teva has recognized PLIVA, and therefore Croatia and its people, as a guarantee for its further successful operations. We are continuously investing in further education of our employees to enable them to successfully respond to current and future challenges in the healthcare industry”.

Following the official opening of the R&D extension, Teva Croatia organized an open door event for all those interested in visiting and learning more about the future of the pharmaceutical industry.
Hundreds of students and other curious visitors were very satisfied with what they learned from Teva’s scientists and experts. Teva’s talented staff were happy to share their knowledge, and explain about their everyday activities and their mission to help patients worldwide.